News GSK delivers in new CEO Miels' first financial update Luke Miels' first financial results since taking over as chief executive of GSK revealed a jump in sales and profits.
News Walmsley to leave GSK in surprise exit This week has kicked off with the news that Emma Walmsley is standing down as chief executive of GSK after eight years, to be replaced by Luke Miels.
News GSK's new pharma chief Miels to join in September Luke Miels to start role after GSK and AZ end contract row.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
